Cabergoline 70512-0860
Product NDC
70512-0860- Manufacturer
- Sola Pharmaceuticals, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 8, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA076310
Need to source Cabergoline? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cabergoline | .5 mg/1 |
Drug Class
Ergot Derivative [EPC]Ergolines [CS]Ergot Derivative [EPC]
Packaging Options(1)
8 TABLET in 1 BOTTLE (70512-860-08)